AMG:ETR
Amgen Inc
407,55 €
arrow_downward
-1,68%(-6,95) 1 d.
18. 11., 17:35:39 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre AMG…
Otvoriť
413,70 €
Vysoká
416,55 €
Nízka
407,55 €
Trh. kap.
240,11 mld.
Priem. obj.
474,00
Objem
422,00
Max. za 52 týž.
438,75 €
Min. za 52 týž.
267,60 €
Počet zamestnancov
32 tis.
Otvoriť
413,70 €
Vysoká
416,55 €
Nízka
407,55 €
Trh. kap.
240,11 mld.
Priem. obj.
474,00
Objem
422,00
Max. za 52 týž.
438,75 €
Min. za 52 týž.
267,60 €
Počet zamestnancov
32 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
CryptoRank
·
pred 8 hodinami
Wrapped Amgen Tokenized Stock (xStock): Funding, Investors, Team and Key Events
Traders Union
·
pred 8 hodinami
Amgen stock slides while oversold readings limit further downside risk
TradingKey
·
pred 9 hodinami
Amgen Inc Stock (AMGN) Moved Down by 3.21% on Nov 18: What Signal Does It Send?
Reuters
·
pred 1 týždňom
Amgen's Sjogren's drug cuts disease activity in trial
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Informácie o subjekte Amgen Inc
Generálny riaditeľRobert A. Bradway
Zamestnanci31,5 tis.
Dátum založenia1980
Hlavné sídloThousand Oaks, Kalifornia, Spojené štáty americké
OdvetvieHealth Care
Odvetvie-
Webamgen.com